dc.contributor.author |
Holford, Nick |
|
dc.coverage.spatial |
England |
|
dc.date.accessioned |
2022-07-28T04:05:22Z |
|
dc.date.available |
2022-07-28T04:05:22Z |
|
dc.date.issued |
2022-03-29 |
|
dc.identifier.citation |
(2022). Journal of Clinical Pharmacology. |
|
dc.identifier.issn |
0091-2700 |
|
dc.identifier.uri |
https://hdl.handle.net/2292/60628 |
|
dc.format.medium |
Print-Electronic |
|
dc.language |
eng |
|
dc.publisher |
Wiley |
|
dc.relation.ispartofseries |
Journal of clinical pharmacology |
|
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
|
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
|
dc.subject |
Science & Technology |
|
dc.subject |
Life Sciences & Biomedicine |
|
dc.subject |
Pharmacology & Pharmacy |
|
dc.subject |
1115 Pharmacology and Pharmaceutical Sciences |
|
dc.title |
Commentary on Pharmacologically Meaningful Half-Life. |
|
dc.type |
Journal Article |
|
dc.identifier.doi |
10.1002/jcph.2051 |
|
dc.date.updated |
2022-06-07T16:37:02Z |
|
dc.rights.holder |
Copyright: The author |
en |
dc.identifier.pmid |
35348233 (pubmed) |
|
pubs.author-url |
https://www.ncbi.nlm.nih.gov/pubmed/35348233 |
|
pubs.publication-status |
Published |
|
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Journal Article |
|
pubs.elements-id |
891833 |
|
pubs.org-id |
Medical and Health Sciences |
|
pubs.org-id |
Medical Sciences |
|
pubs.org-id |
Pharmacology |
|
dc.identifier.eissn |
1552-4604 |
|
pubs.record-created-at-source-date |
2022-06-08 |
|
pubs.online-publication-date |
2022-03-29 |
|